vimarsana.com

Latest Breaking News On - Cantex pharmaceuticals - Page 1 : vimarsana.com

FDA Grants Orphan Drug Designation to Azeliragon for Pancreatic Cancer

The FDA has granted orphan drug designation to azeliragon as a potential therapeutic option for patients with pancreatic cancer.

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF PANCREATIC CANCER

Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed, announced today that the U.S..

The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity

The aspirin conundrum: navigating negative re

A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA (“The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity”).

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.